Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 ConferenceBusiness Wire • 3 days ago
At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and...
Share to Feed
Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and...
Bruker Corporation (Nasdaq: BRKR) today announced that it has entered into a definitive acquisition agreement with NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading...
Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) systems, today announces novel magnet technology and analytical solutions to support broad adoption of NMR...
Bruker Corporation (Nasdaq: BRKR), the leading provider of nuclear magnetic resonance (NMR) spectroscopy solutions, announces the introduction of novel high-resolution solid-state NMR scientific...
Strategic partnership expands Biognosys' services to include Alamar's NULISA assays as well as joint scientific research in biofluid-based proteomicsComplementary value of Biognosys' DIA-MS unbiased...
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research Biognosys and Alamar Biosciences Forge Strategic Partnership in...
Blue Trust Inc. increased its holdings in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 14.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange...
Bruker Corporation (NASDAQ: BRKR) has been selected as the Instrument Business Outlook (IBO) Company of the Year for 2023. IBO cited Brukers double-digit organic revenue growth in 2023 in all major...
Legacy Wealth Asset Management LLC grew its holdings in Bruker Co. (NASDAQ:BRKR Free Report) by 5.7% during the 4th quarter, according to the company in its most recent disclosure with the...